These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 29287266

  • 1. Stability of infliximab solutions in different temperature and dilution conditions.
    Tokhadze N, Chennell P, Le Basle Y, Sautou V.
    J Pharm Biomed Anal; 2018 Feb 20; 150():386-395. PubMed ID: 29287266
    [Abstract] [Full Text] [Related]

  • 2. Comparative Stability Studies of Different Infliximab and Biosimilar CT-P13 Clinical Solutions by Combined Use of Physicochemical Analytical Techniques and Enzyme-Linked Immunosorbent Assay (ELISA).
    Hermosilla J, Sánchez-Martín R, Pérez-Robles R, Salmerón-García A, Casares S, Cabeza J, Cuadros-Rodríguez L, Navas N.
    BioDrugs; 2019 Apr 20; 33(2):193-205. PubMed ID: 30875076
    [Abstract] [Full Text] [Related]

  • 3. One-month stability study of a biosimilar of infliximab (Remsima®) after dilution and storage at 4°C and 25°C.
    Vieillard V, Astier A, Sauzay C, Paul M.
    Ann Pharm Fr; 2017 Jan 20; 75(1):17-29. PubMed ID: 27659414
    [Abstract] [Full Text] [Related]

  • 4. Stability of ipilimumab in its original vial after opening allows its use for at least 4 weeks and facilitates pooling of residues.
    Bardo-Brouard P, Vieillard V, Shekarian T, Marabelle A, Astier A, Paul M.
    Eur J Cancer; 2016 May 20; 58():8-16. PubMed ID: 26922168
    [Abstract] [Full Text] [Related]

  • 5. Long-term stability of diluted solutions of the monoclonal antibody rituximab.
    Paul M, Vieillard V, Jaccoulet E, Astier A.
    Int J Pharm; 2012 Oct 15; 436(1-2):282-90. PubMed ID: 22789912
    [Abstract] [Full Text] [Related]

  • 6. Physicochemical stability study of MYL-1401O, a biosimilar of trastuzumab, following a transient temperature excursion.
    Guyader GL, Vieillard V, Paul M.
    J Oncol Pharm Pract; 2021 Jun 15; 27(4):847-856. PubMed ID: 32660375
    [Abstract] [Full Text] [Related]

  • 7. Part 1: Physicochemical characterization of bevacizumab in undiluted 25 mg/mL drug product solutions: Comparison of originator with a biosimilar candidate.
    Arvinte T, Palais C, Poirier E, Cudd A, Rajendran S, Brokx S, Dowd J.
    J Pharm Biomed Anal; 2019 Oct 25; 175():112742. PubMed ID: 31344647
    [Abstract] [Full Text] [Related]

  • 8. Biosimilarity under stress: A forced degradation study of Remicade® and Remsima™.
    Pisupati K, Benet A, Tian Y, Okbazghi S, Kang J, Ford M, Saveliev S, Sen KI, Carlson E, Tolbert TJ, Ruotolo BT, Schwendeman SP, Schwendeman A.
    MAbs; 2017 Oct 25; 9(7):1197-1209. PubMed ID: 28787231
    [Abstract] [Full Text] [Related]

  • 9. Assessing the Extended In-Use Stability of the Infliximab Biosimilar PF-06438179/GP1111 Following Preparation for Intravenous Infusion.
    Vimpolsek M, Gottar-Guillier M, Rossy E.
    Drugs R D; 2019 Jun 25; 19(2):127-140. PubMed ID: 30810925
    [Abstract] [Full Text] [Related]

  • 10. Part 2: Physicochemical characterization of bevacizumab in 2 mg/mL antibody solutions as used in human i.v. administration: Comparison of originator with a biosimilar candidate.
    Arvinte T, Palais C, Poirier E, Cudd A, Rajendran S, Brokx S, Dowd J.
    J Pharm Biomed Anal; 2019 Nov 30; 176():112802. PubMed ID: 31446298
    [Abstract] [Full Text] [Related]

  • 11. Stability assessment of antibody-drug conjugate Trastuzumab emtansine in comparison to parent monoclonal antibody using orthogonal testing protocol.
    Mohamed HE, Mohamed AA, Al-Ghobashy MA, Fathalla FA, Abbas SS.
    J Pharm Biomed Anal; 2018 Feb 20; 150():268-277. PubMed ID: 29258046
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-term stability of bevacizumab repackaged in 1mL polypropylene syringes for intravitreal administration.
    Paul M, Vieillard V, Roumi E, Cauvin A, Despiau MC, Laurent M, Astier A.
    Ann Pharm Fr; 2012 May 20; 70(3):139-54. PubMed ID: 22655582
    [Abstract] [Full Text] [Related]

  • 14. Modeling study of long-term stability of the monoclonal antibody infliximab and biosimilars using liquid-chromatography-tandem mass spectrometry and size-exclusion chromatography-multi-angle light scattering.
    Legrand P, Dufaÿ S, Mignet N, Houzé P, Gahoual R.
    Anal Bioanal Chem; 2023 Jan 20; 415(1):179-192. PubMed ID: 36449030
    [Abstract] [Full Text] [Related]

  • 15. Characterization of Inherent Particles and Mechanism of Thermal Stress Induced Particle Formation in HSV-2 Viral Vaccine Candidate.
    Li L, Kirkitadze M, Bhandal K, Roque C, Yang E, Carpick B, Rahman N.
    Curr Pharm Biotechnol; 2017 Nov 10; 18(8):638-647. PubMed ID: 28914197
    [Abstract] [Full Text] [Related]

  • 16. Long-term Stability of Esomeprazole in 5% Dextrose Infusion Polyolefin Bags at 5 degrees C +/- 3 degrees C after Microwave Freeze-thaw Treatment.
    Hecq JD, Rolin C, Godet M, Gillet P, Jamart J, Galanti LM.
    Int J Pharm Compd; 2015 Nov 10; 19(6):521-4. PubMed ID: 26891566
    [Abstract] [Full Text] [Related]

  • 17. Conformational analysis of protein secondary structure during spray-drying of antibody/mannitol formulations.
    Schüle S, Friess W, Bechtold-Peters K, Garidel P.
    Eur J Pharm Biopharm; 2007 Jan 10; 65(1):1-9. PubMed ID: 17034996
    [Abstract] [Full Text] [Related]

  • 18. Equilibrium studies of protein aggregates and homogeneous nucleation in protein formulation.
    Kiese S, Pappenberger A, Friess W, Mahler HC.
    J Pharm Sci; 2010 Feb 10; 99(2):632-44. PubMed ID: 19548315
    [Abstract] [Full Text] [Related]

  • 19. Mechanically-induced aggregation of the monoclonal antibody cetuximab.
    Lahlou A, Blanchet B, Carvalho M, Paul M, Astier A.
    Ann Pharm Fr; 2009 Sep 10; 67(5):340-52. PubMed ID: 19695370
    [Abstract] [Full Text] [Related]

  • 20. Physicochemical stability of PF-06439535 (bevacizumab-bvzr; Zirabev®), a bevacizumab biosimilar, under extended in-use conditions.
    Weiser S, Burns C, Zartler ER.
    J Oncol Pharm Pract; 2023 Jul 10; 29(5):1032-1043. PubMed ID: 35312402
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.